Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Long-term characteristics of long-COVID following hospitalization

Long-term characteristics of long-COVID following hospitalization

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

Prediction of waning COVID-19 vaccine efficacy against Omicron variant

Prediction of waning COVID-19 vaccine efficacy against Omicron variant

Analysis of the alteration of neutralizing titers with Omicron pseudovirus

Analysis of the alteration of neutralizing titers with Omicron pseudovirus

Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing

Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing

Comparison of RBD/ACE2 receptor complex in wild type SARS-CoV-2 and Omicron variant

Comparison of RBD/ACE2 receptor complex in wild type SARS-CoV-2 and Omicron variant

Study provides a more effective treatment approach to preventing graft-versus-host-disease

Study provides a more effective treatment approach to preventing graft-versus-host-disease

Antibody-like proteins derived from sharks may be used to combat future SARS outbreaks

Antibody-like proteins derived from sharks may be used to combat future SARS outbreaks

NIH scientists highlight the urgent need for universal coronavirus vaccines

NIH scientists highlight the urgent need for universal coronavirus vaccines

KHN’s ‘What the Health?’: Oh, oh, omicron

KHN’s ‘What the Health?’: Oh, oh, omicron

New study demonstrates SARS-CoV-2 Omicron antibody escape

New study demonstrates SARS-CoV-2 Omicron antibody escape

Moderna booster vaccination overcomes SARS-CoV-2 Omicron variant antibody escape

Moderna booster vaccination overcomes SARS-CoV-2 Omicron variant antibody escape

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Study suggests convalescent plasma appears safe but does not prevent SARS-CoV-2 infection

Study details the effectiveness of face masks to reduce the spread of respiratory infections

Study details the effectiveness of face masks to reduce the spread of respiratory infections

Therapeutic antibodies deemed ineffective against Omicron variant of SARS-CoV-2

Therapeutic antibodies deemed ineffective against Omicron variant of SARS-CoV-2

Capability of BNT162b2 vaccine given in 2 or 3 doses to neutralize SARS-CoV-2 Omicron

Capability of BNT162b2 vaccine given in 2 or 3 doses to neutralize SARS-CoV-2 Omicron

Experimental and computational synergy considered a promising approach in COVID-19 patients

Experimental and computational synergy considered a promising approach in COVID-19 patients

T cell responses remain broadly robust against Omicron variant of SARS-CoV-2

T cell responses remain broadly robust against Omicron variant of SARS-CoV-2

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.